Compare Cadila Healthcare with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ORCHID PHARMA LTD - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ORCHID PHARMA LTD CADILA HEALTHCARE/
ORCHID PHARMA LTD
 
P/E (TTM) x 14.7 -0.5 - View Chart
P/BV x 2.9 0.1 2,434.9% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 CADILA HEALTHCARE   ORCHID PHARMA LTD
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ORCHID PHARMA LTD
Sep-13
CADILA HEALTHCARE/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs558194 287.6%   
Low Rs36235 1,032.9%   
Sales per share (Unadj.) Rs116.3276.5 42.1%  
Earnings per share (Unadj.) Rs17.9-79.2 -22.6%  
Cash flow per share (Unadj.) Rs23.1-43.5 -53.2%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.453.9 158.4%  
Shares outstanding (eoy) m1,023.7470.45 1,453.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.00.4 954.6%   
Avg P/E ratio x25.7-1.4 -1,780.0%  
P/CF ratio (eoy) x19.9-2.6 -754.3%  
Price / Book Value ratio x5.42.1 253.5%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6648,067 5,834.8%   
No. of employees `00011.82.8 422.1%   
Total wages/salary Rs m18,5452,527 733.9%   
Avg. sales/employee Rs Th10,072.76,956.1 144.8%   
Avg. wages/employee Rs Th1,569.1902.5 173.9%   
Avg. net profit/employee Rs Th1,547.7-1,993.0 -77.7%   
INCOME DATA
Net Sales Rs m119,04919,477 611.2%  
Other income Rs m1,132407 278.0%   
Total revenues Rs m120,18119,884 604.4%   
Gross profit Rs m28,4751,103 2,582.5%  
Depreciation Rs m5,3882,519 213.9%   
Interest Rs m9115,227 17.4%   
Profit before tax Rs m23,308-6,236 -373.8%   
Minority Interest Rs m62820 3,187.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m5,644-125 -4,508.0%   
Profit after tax Rs m18,292-5,580 -327.8%  
Gross profit margin %23.95.7 422.5%  
Effective tax rate %24.22.0 1,206.1%   
Net profit margin %15.4-28.7 -53.6%  
BALANCE SHEET DATA
Current assets Rs m82,00511,014 744.5%   
Current liabilities Rs m60,72032,060 189.4%   
Net working cap to sales %17.9-108.1 -16.5%  
Current ratio x1.40.3 393.1%  
Inventory Days Days7395 77.1%  
Debtors Days Days9834 293.0%  
Net fixed assets Rs m83,70329,440 284.3%   
Share capital Rs m1,024705 145.4%   
"Free" reserves Rs m86,4212,043 4,230.9%   
Net worth Rs m87,4453,800 2,301.2%   
Long term debt Rs m25,5519,018 283.3%   
Total assets Rs m180,65346,510 388.4%  
Interest coverage x26.6-0.2 -13,766.1%   
Debt to equity ratio x0.32.4 12.3%  
Sales to assets ratio x0.70.4 157.4%   
Return on assets %10.6-0.8 -1,398.6%  
Return on equity %20.9-146.9 -14.2%  
Return on capital %22.0-3.7 -588.8%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m42,6837,513 568.1%   
Fx outflow Rs m11,2425,649 199.0%   
Net fx Rs m31,4411,865 1,686.3%   
CASH FLOW
From Operations Rs m9,1931,682 546.6%  
From Investments Rs m-9,737-9,860 98.7%  
From Financial Activity Rs m5156,644 7.8%  
Net Cashflow Rs m-29-1,535 1.9%  

Share Holding

Indian Promoters % 74.8 32.3 231.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 4.6 180.4%  
FIIs % 5.9 3.3 178.8%  
ADR/GDR % 0.0 4.6 -  
Free float % 11.0 55.3 19.9%  
Shareholders   44,069 84,811 52.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   TTK HEALTHCARE  ALEMBIC LTD  CIPLA  AJANTA PHARMA  SUVEN LIFESCIENCES  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms Over 1,900 Points after Government Slashes Corporate Tax Rates(12:30 pm)

Share markets in India jumped sharply after FM Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 20, 2019 03:35 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS